Reversal of MDR1 gene-dependent multidrug resistance in HL60/HT9 cells using short hairpin RNA expression vectors

Cancer Biotherapy and Radiopharmaceuticals

Volumn 25, Issue 2, 2010, Pages 171-177

  Shao, Shu Li ^a,b   Zhang, Wei Wei ^a   Li, Xu Yan ^a   Zhang, Zhen Zhu ^a   Yun, Dong Ze ^a   Fu, Bo ^a   Zuo, Ming Xue ^b  

^a QIQIHAR UNIVERSITY   (China)

^b BEIJING NORMAL UNIVERSITY   (China)

Author keywords

Gene silencing; Human promyelocytic leukemia cell HT9; MDR; Small interference RNA

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CURCUMIN; GLYCOPROTEIN P; HARRINGTONINE; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; PLASMID VECTOR; SHORT HAIRPIN RNA;

ARTICLE; CELL STRAIN HL 60; CONTROLLED STUDY; DRUG EFFICACY; DRUG SELECTIVITY; DRUG SENSITIVITY; EXPRESSION VECTOR; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RECOMBINANT PLASMID; RNA INTERFERENCE; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CELL LINE, TUMOR; CURCUMIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC VECTORS; HUMANS; LEUKEMIA; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 77951950664     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2008.0611     Document Type: Article

References (29)

1. Ling V. Multidrug resistance and P-glycoprotein expression. Ann N Y Acad Sci 1987;507:7.
2. Ford JM, Hait WN. Pharmacology of drugs that alter multidrug resistance in cancer. Pharmacology 1990;42:155.
3. Sonneveld P, Durie BG, Lokhorst HM, et al. Modulation of multidrug-resistant multiple myeloma by cyclosporin. Lancet 1992;340:255.
4. Volm M. Multidrug resistance and its reversal. Anticancer Res 1998;18:2905.
5. Liu C, Qureshi IA, Ding X, et al. Modulation of multidrug resistance gene (mdr-1) with antisense oligodeoxynucleotides. Clin Sci 1996;91:93.
6. Stuart DD, Kao GY, Allen TM. A novel, long-circulating, and functional liposomal formulation of antisense oligodeoxynucleotides targeted against MDR1. Cancer Gene Ther 2000;7:466.
7. Holm PS, Scanlon KJ, Dietel M. Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme. Br J Cancer 1994;70:239.
8. Fire A, Xu S, Montgomery MK, et al. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998;39:1806.
9. Ngo H, Tschudi C, Gull K, et al. Double-stranded RNA induces mRNA degradation in Trypanosoma brucei. Proc Natl Acad Sci USA 1998;95:14687.
10. Kennerdell JR, Carthew RW. Heritable gene silencing in Drosophila using double-stranded RNA. Nat Biotechnol 2000;17:896.
11. Paddison PJ, Caudy AA, Hannon GJ. Stable suppression of gene expression by RNAi in mammalian cells. Proc Natl Acad Sci U S A 2002;99:1443.
12. Svoboda P, Stein P, Hayashi H, et al. Selective reduction of dormant maternal mRNAs in mouse oocytes by RNA interference. Development 2000;127:4147.
13. Billy E, Bromdani V, Zhang H, et al. Specific interference with gene expression induced by long double-stranded RNA in mouse embryonal teratocarcinoma cell lines. Proc Natl Acad Sci U S A 2001;98:14428.
14. Elbashir SM, Martinez J, Patkaniowska A, et al. Functional anatomy of shRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 2001;20:6877.
15. Yu JY, DeRuiter SL, Turner DL, et al. RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci U S A 2002;99:6047.
16. Kisielow M, Kleiner S, Nagasawa M, et al. Isoformspecific knockdown and expression of adaptor protein ShcA using small interfering RNA. Biochem J 2002;363 (pt1) : 1.
17. Elbashir SM, Harborth J, Lendeckel W, et al. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature (Lond) 2001;411:494.
18. Jacque JM, Triques K, Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature (Lond) 2002;418:435.
19. Novina CD, Murray MF, Dykxhoom DM, et al. siRNA-directed inhibition of HIV-1 infection. Nat Med 2002;8:681.
20. Cobun GA, Cullen BR. Potent and specific inhibition of human immumodeficiency virus type 1 replication by RNA interference. J Virol 2002;76:9225.
21. Lee NS, Dohjima T, Bauer G, et al. Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 2002;20:500.
22. Xu D, Ye D, Fisher M, et al. Selective inhibition of P-glycoprotein expression in multidrug-resistant tumor cells by a designed transcriptional regulator. J Pharmacol Exp Ther 2002;302:963.
23. Mechetner EB, Roninson IB. Efficient inhibition of P-glycoprotein- mediated multidrug resistance with a monoclonal antibody. Proc Natl Acad Sci U S A 1992;89:5824.
24. Astriab-Fisher A, Sergueev DS, Fisher M, et al. Antisense inhibition of P-glycoprotein expression using peptideoligonucleotide conjugates. Biochem Pharmacol 2000;60:83.
25. Yang JM, Vassil AD, Hait WN. Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway. Mol Pharmacol 2001;60:674.
26. Miyagishi M, Taira K. U6 promoter driven shRNAs with four ruidine 30 overhangs efficiently suppress targeted gene expression in mammalian cells. Nat Biotechnol 2002;20:497.
27. Czauderna F, Fechtner M, Aygun H, et al. Functional studies of the PI (3)-kinase signaling pathway employing synthetic and expressed shRNA. Nucleic Acid Res 2003;31:670.
28. Yague E, Higgins CF, Raguz S. Complete reversal of multidrug resistance by stable expression of small interfering RNAs targeting MDR1. Gene Therapy 2004;11:1170.
29. Gao P, Zhou GY, Guo LL, et al. Reversal of drug resistance in breast carcinoma cells by anti-mdr1 ribozyme regulated by the tumor-specific MUC-1 promoter. Cancer Lett 2007;256:81.